Human data is still limited, but the improved bioavailability helps explain why some patients can eventually reduce to three times weekly dosing
It is also not appropriate for those who are looking for an instant or short-term weight loss fix
Use multiple metrics: Weekly weigh-ins at the same time (typically morning, after bathroom, before food) provide trend data despite daily fluctuations
Factors influencing symptom severity include: Rate of dose titration (slower escalation reduces symptoms) Meal size and composition (large, high-fat meals exacerbate symptoms) Individual variation in GLP-1 receptor sensitivity Concurrent medications affecting gut motility Patients should be counselled that these effects are pharmacologically expected and usually temporary, but persistent or severe symptoms warrant medical review to exclude complications such as pancreatitis, cholelithiasis, or cholecystitis
Kratz F, Mller-Driver R, Hofmann I, Drevs J, Unger C